| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/07/2007 | US20070128199 DSP-3 dual-specificity phosphatase |
| 06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
| 06/07/2007 | US20070128197 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 06/07/2007 | US20070128196 Methods and compositions for inhibiting angiogenesis |
| 06/07/2007 | US20070128195 Interleukins; Antigen binding fragment that binds to polypeptide of given sequence; immunogenic |
| 06/07/2007 | US20070128194 monoclonal antibody specific for human NDRG 2 (N-myc downstream regulated gene 2) protein; used to investigate and treat intractable diseases and cancers using the dendritic cell |
| 06/07/2007 | US20070128193 GLP-1 agonists, compositions, methods and uses |
| 06/07/2007 | US20070128192 Human antibody molecules for il-13 |
| 06/07/2007 | US20070128191 Polyclonal antibodies, preparation method thereof and use of same |
| 06/07/2007 | US20070128190 Anti-alpha2 integrin antibodies and their uses |
| 06/07/2007 | US20070128189 Monoclonal antibodies as immunosuppressants, cytokine antagonists; antiinflammatory agents; cytokine suppressive antiinflammatory drug; biodrugs |
| 06/07/2007 | US20070128188 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 06/07/2007 | US20070128187 modulating lipid levels and/or bone mass; diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis; bone disorders; Paget's disease |
| 06/07/2007 | US20070128186 Proliferative glomerulonephritis-related gene |
| 06/07/2007 | US20070128185 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 06/07/2007 | US20070128184 Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins |
| 06/07/2007 | US20070128183 Td antigens |
| 06/07/2007 | US20070128164 Poxvirus vector comprising 5T4 tumour-associated antigen (TAA) for vaccinating cell against cell proliferative disorders |
| 06/07/2007 | US20070128163 Adeno-associated virus-mediated delivery of angiogenic factors |
| 06/07/2007 | US20070128159 Chemokines as adjuvants of immune response |
| 06/07/2007 | US20070128150 3-Maleimidyl-N-(2-{[3-maleimidyl-propionyl]-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-amino}-ethyl)-N-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-propionamide linked to 2 polyoxyethyelne glycol residue and two antibodies or fragments; conjugate; biodegradable |
| 06/07/2007 | US20070128117 Ultrasound contrast agents and process for the preparation thereof |
| 06/07/2007 | US20070128113 Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | US20070128111 Immunoglobulin for use in treatment and prevention of immunological and cancer disorders; immunotherapy; antibodies with modified hinge cysteine residues |
| 06/07/2007 | CA2632866A1 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2632797A1 Compositions and methods relating to treatment of cancer and infectious diseases using toll like receptor agonists |
| 06/07/2007 | CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 06/07/2007 | CA2631931A1 Cancer therapies and pharmaceutical compositions used therein |
| 06/07/2007 | CA2631812A1 Chimeric viruses presenting non-native surface proteins and uses thereof |
| 06/07/2007 | CA2631733A1 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 06/07/2007 | CA2631630A1 Fc.gamma. polymorphisms for predicting disease and treatment outcome |
| 06/07/2007 | CA2631598A1 Induction of mucosal tolerance to antigens |
| 06/07/2007 | CA2631382A1 Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences |
| 06/07/2007 | CA2631312A1 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 06/07/2007 | CA2631292A1 Derivatised wt1 cancer antigen peptides and their use |
| 06/07/2007 | CA2631195A1 Monoclonal antibodies against amyloid beta protein and uses thereof |
| 06/07/2007 | CA2631181A1 Treatment of conditions involving demyelination |
| 06/07/2007 | CA2630648A1 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof |
| 06/07/2007 | CA2630547A1 Vaccines containing non-live antigenic vectors |
| 06/07/2007 | CA2630429A1 Vaccines |
| 06/07/2007 | CA2629850A1 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/06/2007 | EP1793005A1 NOVEL USE OF PrPP AND RECEPTOR THEREOF |
| 06/06/2007 | EP1793000A1 Transgenically produced non-secreted proteins |
| 06/06/2007 | EP1792996A1 Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
| 06/06/2007 | EP1792995A2 Chlamydia secretory locus orf and uses thereof |
| 06/06/2007 | EP1792994A2 Vaccines of bacterial outer membrane vesicles |
| 06/06/2007 | EP1792992A1 Antigenic protein originating in Malassezia |
| 06/06/2007 | EP1792991A1 Human CTLA-4 antibodies and their uses |
| 06/06/2007 | EP1792989A1 13 Transmembrane protein expressed in prostate cancer |
| 06/06/2007 | EP1792988A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 06/06/2007 | EP1792987A1 Method of producing glycoprotein composition |
| 06/06/2007 | EP1792628A1 Vaccines |
| 06/06/2007 | EP1792627A1 Modulation of the immune response by administration of intralymphatic transduction allergen (ITAG-)-molecules |
| 06/06/2007 | EP1792625A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 06/06/2007 | EP1791978A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 06/06/2007 | EP1791968A2 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 06/06/2007 | EP1791967A2 Methods and compositions relating to mannuronic acid specific binding peptides |
| 06/06/2007 | EP1791873A1 New polymorphic form of inulin and uses thereof |
| 06/06/2007 | EP1791870A1 Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 06/06/2007 | EP1791867A2 Binding member towards pneumolysin |
| 06/06/2007 | EP1791864A2 Methods of using death receptor ligands and cd20 antibodies |
| 06/06/2007 | EP1791860A1 Purification process for bacterial cytolysin |
| 06/06/2007 | EP1791566A2 Product and process for inhibition of biofilm development |
| 06/06/2007 | EP1791564A2 Drying process for preserving an active agent as a highly viscous liquid |
| 06/06/2007 | EP1791563A2 Anti-cd154 antibodies |
| 06/06/2007 | EP1791562A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 06/06/2007 | EP1791561A2 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 06/06/2007 | EP1791560A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 06/06/2007 | EP1791559A2 Immunogenic composition |
| 06/06/2007 | EP1791558A2 Vaccines comprising plasmodium antigens |
| 06/06/2007 | EP1791556A2 Modified hiv-1 envelope proteins |
| 06/06/2007 | EP1487998B1 Methods for diagnosing and treating schizophrenia |
| 06/06/2007 | EP1476548B1 Process of cell electrofusion |
| 06/06/2007 | EP1181056B1 Lim mineralization protein splice variants |
| 06/06/2007 | EP1009826B1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 06/06/2007 | EP0941478B2 Assay method for peptide specific t-cells |
| 06/06/2007 | EP0939824B1 Reagents and methods useful for detecting diseases of the breast |
| 06/06/2007 | EP0886679B1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/06/2007 | EP0703981B1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 06/06/2007 | CN1977045A SARS nucleic acids, proteins, vaccines, and uses thereof |
| 06/06/2007 | CN1976951A Anti-EpCAM immunoglobulins |
| 06/06/2007 | CN1976727A Methods and compositions for the treatment of polycystic diseases |
| 06/06/2007 | CN1976725A Dimensional analysis of saccharide conjugates with GPC & SEC-MALS |
| 06/06/2007 | CN1976724A Meningococcal conjugate vaccination |
| 06/06/2007 | CN1976721A Method to reduce hepatotoxicity of FAS-mediated apoptosis-inducing agents |
| 06/06/2007 | CN1976720A Compositions and methods for treatment of severe acute respiratory syndrome (SARS) |
| 06/06/2007 | CN1976719A PRRSV subunit vaccines |
| 06/06/2007 | CN1976718A Vaccine against HPV 16 and HPV 18 and at least another HPV type selected from HPV 31, 45 or 52 |
| 06/06/2007 | CN1976717A Safe mutant viral vaccines |
| 06/06/2007 | CN1976716A Combined meningococcal conjugates with common carrier protein |
| 06/06/2007 | CN1976687A Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer |
| 06/06/2007 | CN1973903A Oral vaccine of recombinant gene for preventing Helicobacter pylori infection and its prepn process |
| 06/06/2007 | CN1973899A Immunomodulator for treating malignant tumor |
| 06/06/2007 | CN1320114C Variable region gene in heavy chain and light chain of anti Pgp monoclone antibody and its application |
| 06/06/2007 | CN1320104C Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 06/06/2007 | CN1319991C Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/06/2007 | CN1319596C Preparation process of S190 polypeptide vaccine and its application in resisting SARS virus |
| 06/06/2007 | CN1319595C Method for preparing agglutinative antigen of cholera fowl |
| 06/05/2007 | US7227011 Nucleic acid vaccines for prevention of flavivirus infection |